The impact of chronic kidney disease as a predictor of major cardiac events in patients with no evidence of coronary artery disease

Journal of Cardiology

Volumn 55, Issue 3, 2010, Pages 328-336

  Furuhashi, Tatsuhiko ^a   Moroi, Masao ^a   Joki, Nobuhiko ^a   Hase, Hiroki ^a   Masai, Hirofumi ^a   Kunimasa, Taeko ^a   Nakazato, Ryo ^a   Fukuda, Hiroshi ^a   Sugi, Kaoru ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Coronary artery disease; Prognosis; Radionuclide imaging; Renal function; Stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; THALLIUM 201;

ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE PERFUSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREADMILL EXERCISE; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 77952102347     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.12.009     Document Type: Article

References (40)

1. Brown K.A. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol 3 (1996) 516-537
2. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., Friedman J., and Diamond G.A. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
3. Iskander S., and Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32 (1998) 57-62
4. Shaw L.J., Hendel R., Borges-Neto S., Lauer M.S., Alazraki N., Burnette J., Krawczynska E., Cerqueira M., and Maddahi J. Myoview Multicenter Registry. Prognostic value of normal exercise and adenosine 99mTc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 44 (2003) 134-139
5. Vanzetto G., Ormezzano O., Fagret D., Comet M., Denis B., and Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 100 (1999) 1521-1527
6. Underwood S.R., Anagnostopoulos C., Cerqueira M., Ell P.J., Flint E.J., Harbinson M., Kelion A.D., Al-Mohammad A., Prvulovich E.M., Shaw L.J., Tweddel A.C., British Cardiac Society, British Nuclear Cardiology Society, British Nuclear Medicine Society, Royal College of Physicians of London, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imag 31 (2004) 261-291
7. Matsuo S., Nakajima K., Horie M., Nakae I., Nishimura T., and J-ACCESS Investigators. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J 72 (2008) 611-617
8. Yang M.F., Dou K.F., Liu X.J., Yang Y.J., and He Z.X. Prognostic value of normal exercise 99mTc-sestamibi myocardial tomography in patients with angiographic coronary artery disease. Nucl Med Commun 27 (2006) 333-338
9. Abdel-Fattah A., Kamal A.M., Pancholy S., Ghods M., Russell J., Cassel D., Wasserleben V., Heo J., and Iskandrian A.S. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol 74 (1994) 769-771
10. Giri S., Shaw L.J., Murthy D.R., Travin M.I., Miller D.D., Hachamovitch R., Borges-Neto S., Berman D.S., Waters D.D., and Heller G.V. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
11. Koehli M., Monbaron D., Prior J.O., Calcagni M.L., Fivaz-Arbane M., Stauffer J.C., Gaillard R.C., Bischof Delaloye A., and Ruiz J. SPECT myocardial perfusion imaging: long-term prognostic value in diabetic patients with and without coronary artery disease. Nuklearmedizin 45 (2006) 74-81
12. Hachamovitch R., Hayes S., Friedman J.D., Cohen I., Shaw L.J., Germano G., and Berman D.S. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan?. J Am Coll Cardiol 41 (2003) 1329-1340
13. Meisinger C., Doring A., Lowel H., and KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 27 (2006) 1245-1250
14. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
15. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., Coresh J., Levey A.S., and Sarnak M.J. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2004) 47-55
16. Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., Griffith J.L., Salem D.N., Levey A.S., and Sarnak M.J. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
17. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., White H.D., Nordlander R., Maggioni A., Dickstein K., Zelenkofske S., Leimberger J.D., Califf R.M., and Pfeffer M.A. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
18. Gibson C.M., Dumaine R.L., Gelfand E.V., Murphy S.A., Morrow D.A., Wiviott S.D., Giugliano R.P., Cannon C.P., Antman E.M., Braunwald E., and TIMI Study Group. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J 25 (2004) 1998-2005
19. Jose P., Skali H., Anavekar N., Tomson C., Krumholz H.M., Rouleau J.L., Moye L., Pfeffer M.A., and Solomon S.D. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 17 (2006) 2886-2891
20. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., and Krumholz H.M. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
21. Go A.S., Yang J., Ackerson L.M., Lepper K., Robbins S., Massie B.M., and Shlipak M.G. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: outcomes and Resource Utilization (ANCHOR) Study. Circulation 113 (2006) 2713-2723
22. Devbhandari M.P., Duncan A.J., Grayson A.D., Fabri B.M., Keenan D.J., Bridgewater B., Jones M.T., and Au J. North West Quality Improvement Programme in Cardiac Interventions. Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: a multi-centre study. Eur J Cardiothorac Surg 29 (2006) 964-970
23. Cooper W.A., O'Brien S.M., Thourani V.H., Guyton R.A., Bridges C.R., Szczech L.A., Petersen R., and Peterson E.D. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113 (2006) 1063-1070
24. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., and Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
25. Sadeghi H.M., Stone G.W., Grines C.L., Mehran R., Dixon S.R., Lansky A.J., Fahy M., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Stuckey T.D., Turco M., and Carroll J.D. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
26. Ladenheim M.L., Pollock B.H., Rozanski A., Berman D.S., Staniloff H.M., Forrester J.S., and Diamond G.A. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 7 (1986) 464-471
27. Berman D.S., Abidov A., Kang X., Hayes S.W., Friedman J.D., Sciammarella M.G., Cohen I., Gerlach J., Waechter P.B., Germano G., and Hachamovitch R. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 11 (2004) 414-423
28. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., Kusek J.W., Van Lente F., and Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
29. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 Suppl. 1 (2002) S1-S266
30. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.F., Powe N.R., and Siscovick D. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
31. Resnick H.E., Lindsay R.S., McDermott M.M., Devereux R.B., Jones K.L., Fabsitz R.R., and Howard B.V. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109 (2004) 733-739
32. Nishimura T., Nakajima K., Kusuoka H., Yamashina A., and Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imag 35 (2008) 319-328
33. Berman D., Hachamovitch R., Lewin H., Friedman J., Shaw L., and Germano G. Risk stratification in coronary artery disease: implications for stabilization and prevention. Am J Cardiol 79 (1997) 10-16
34. Berman D.S., Kiat H., Friedman J.D., Wang F.P., van Train K., Matzer L., Maddahi J., and Germano G. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
35. Berman D.S., Hachamovitch R., Kiat H., Cohen I., Cabico J.A., Wang F.P., Friedman J.D., Germano G., Van Train K., and Diamond G.A. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 26 (1995) 639-647
36. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Cabico J.A., Friedman J., and Diamond G.A. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
37. Galassi A.R., Azzarelli S., Tomaselli A., Giosofatto R., Ragusa A., Musumeci S., Tamburino C., and Giuffrida G. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 88 (2001) 101-106
38. Hakeem A., Bhatti S., Dillie K.S., Cook J.R., Samad Z., Roth-Cline M.D., and Chang S.M. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 118 (2008) 2540-2549
39. Culleton B.F., Larson M.G., Parfrey P.S., Kannel W.B., and Levy D. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med 109 (2000) 1-8
40. Grimm Jr. R.H., Svendsen K.H., Kasiske B., Keane W.F., and Wahi M.M. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 52 Suppl. 63 (1997) S10-S14